Over 400 New Jersey Auctions End Today - Bid Now
Over 1650 Total Lots Up For Auction at Four Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/06, NJ 05/08

Global cardiovascular surgical devices market to reach $102252 million by 2025

Press releases may be edited for formatting or style | September 20, 2017 Cardiology Heart Disease
LONDON, Sept. 19, 2017 /PRNewswire/ -- Globally, cardiovascular diseases (CVD) are the primary cause of deaths. Hence, the treatment of these diseases is of utmost priority at present.The global cardiovascular surgical devices market is expected to rise at a CAGR of 8.26% over the forecast period of 2017-2025, generating $102252 million by 2025. The rising incidences of cardiac disorders, growing elderly population coupled with the advances in technology is primarily responsible for propelling the market ahead.

Download the full report: https://www.reportbuyer.com/product/5106690

MARKET INSIGHTS
The Global cardiovascular surgical devices market is segmented on the basis of products and end-users. The products include cardiovascular stents, CRDM, cardiac catheters, surgeries, imaging, interventional guide wires, LAA closure devices, atherectomy devices, etc. The end users for the market are hospitals, ASCs and Physician's offices. Rising demand for minimally invasive procedures and favorable reimbursement policies are hugely benefiting the market growth.

REGIONAL INSIGHTS
The global cardiovascular surgical devices market is geographically spread across North America, Asia-Pacific,Europe and Rest of the World. The Asia-Pacific market is predicted to be the fastest growing market over the forecast period. Advanced robotic surgeries are increasingly being adopted in countries like China, Japan, and South Korea. The North America market is anticipated to hold the highest market share by the year 2025 owing to an increase in the number of life style oriented diseases, technological advancements in cardiology and the rising healthcare expenditure.

COMPETITIVE INSIGHTS
Johnson & Johnson is a global pioneer in diverse health products. Another company, Abbott Vascular Inc includes a range of coronary interventional products such as coronary dilatation catheters, bleed back control valve, coronary guide wires, and coronary drug eluting stents. The other major players in the market include Atricure Inc, Atrium Medical Corp, Berlin Heart Gmbh, Boston Scientific Corporation, Cook Medical Inc, Cordis Corp, Ge Healthcare, Medtronic Plc, Philips Healthcare, St. Jude Medical, Inc, and Toshiba Medical Systems Corporation.

Download the full report: https://www.reportbuyer.com/product/5106690

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

SOURCE ReportBuyer

Back to HCB News

You Must Be Logged In To Post A Comment